GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group NV (NAS:WMGI) » Definitions » Beneish M-Score

Wright Medical Group NV (Wright Medical Group NV) Beneish M-Score : -3.01 (As of Apr. 26, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Wright Medical Group NV Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.01 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Wright Medical Group NV's Beneish M-Score or its related term are showing as below:

WMGI' s Beneish M-Score Range Over the Past 10 Years
Min: -3.56   Med: -2.61   Max: -1.21
Current: -3.01

During the past 12 years, the highest Beneish M-Score of Wright Medical Group NV was -1.21. The lowest was -3.56. And the median was -2.61.


Wright Medical Group NV Beneish M-Score Historical Data

The historical data trend for Wright Medical Group NV's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group NV Beneish M-Score Chart

Wright Medical Group NV Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.21 -3.33 -2.63 -2.32 -2.79

Wright Medical Group NV Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.31 -2.79 -2.90 -3.09 -3.01

Competitive Comparison of Wright Medical Group NV's Beneish M-Score

For the Medical Devices subindustry, Wright Medical Group NV's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group NV's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group NV's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Wright Medical Group NV's Beneish M-Score falls into.



Wright Medical Group NV Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Wright Medical Group NV for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9739+0.528 * 0.9889+0.404 * 0.9303+0.892 * 0.9012+0.115 * 1.0778
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0168+4.679 * -0.060514-0.327 * 1.076
=-2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep20) TTM:Last Year (Sep19) TTM:
Total Receivables was $120.6 Mil.
Revenue was 223.367 + 129.955 + 218.54 + 248.605 = $820.5 Mil.
Gross Profit was 178.226 + 101.232 + 179.625 + 199.06 = $658.1 Mil.
Total Current Assets was $762.9 Mil.
Total Assets was $2,598.7 Mil.
Property, Plant and Equipment(Net PPE) was $260.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $96.3 Mil.
Selling, General, & Admin. Expense(SGA) was $567.1 Mil.
Total Current Liabilities was $907.8 Mil.
Long-Term Debt & Capital Lease Obligation was $736.7 Mil.
Net Income was -19.722 + -59.393 + -14.906 + -16.023 = $-110.0 Mil.
Non Operating Income was -10.162 + 7.462 + 13.707 + 2.477 = $13.5 Mil.
Cash Flow from Operations was 21.346 + -30.273 + 19.331 + 23.328 = $33.7 Mil.
Total Receivables was $137.4 Mil.
Revenue was 212.434 + 229.734 + 230.127 + 238.147 = $910.4 Mil.
Gross Profit was 167.993 + 181.396 + 183.81 + 188.998 = $722.2 Mil.
Total Current Assets was $640.8 Mil.
Total Assets was $2,508.8 Mil.
Property, Plant and Equipment(Net PPE) was $233.5 Mil.
Depreciation, Depletion and Amortization(DDA) was $95.7 Mil.
Selling, General, & Admin. Expense(SGA) was $618.9 Mil.
Total Current Liabilities was $743.7 Mil.
Long-Term Debt & Capital Lease Obligation was $731.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(120.597 / 820.467) / (137.411 / 910.442)
=0.146986 / 0.150928
=0.9739

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(722.197 / 910.442) / (658.143 / 820.467)
=0.793238 / 0.802157
=0.9889

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (762.854 + 260.73) / 2598.719) / (1 - (640.764 + 233.494) / 2508.832)
=0.60612 / 0.651528
=0.9303

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=820.467 / 910.442
=0.9012

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(95.655 / (95.655 + 233.494)) / (96.253 / (96.253 + 260.73))
=0.290613 / 0.269629
=1.0778

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(567.081 / 820.467) / (618.862 / 910.442)
=0.691169 / 0.679738
=1.0168

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((736.668 + 907.803) / 2598.719) / ((731.756 + 743.654) / 2508.832)
=0.632801 / 0.588086
=1.076

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-110.044 - 13.484 - 33.732) / 2598.719
=-0.060514

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Wright Medical Group NV has a M-score of -2.93 suggests that the company is unlikely to be a manipulator.


Wright Medical Group NV Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Wright Medical Group NV's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group NV (Wright Medical Group NV) Business Description

Traded in Other Exchanges
N/A
Address
Prins Bernhardplein 200, Amsterdam, NLD, 1097 JB
Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sports medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.
Executives
Steven P. Wallace officer: President, International 1023 CHERRY ROAD MEMPHIS TN 38117
Barry J. Regan officer: SVP, Operations 1023 CHERRY ROAD, MEMPHIS TN 38117
Kevin C. Smith officer: SVP, Quality and Regulatory 1023 CHERRY ROAD MEMPHIS TN 38117
Jason D. Asper officer: SVP, Chief Digital Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Tim Lanier officer: President, Upper Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Patrick Fisher officer: President, Lower Extremities 1023 CHERRY ROAD MEMPHIS TN 38117
Jonathan Wesley Porter officer: SVP, Chief Compliance Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Julie Andrews officer: SVP, Global Finance 5677 AIRLINE ROAD, ARLINGTON TN 38002
Jennifer S. Walker officer: SVP, Process Improvement 5677 AIRLINE ROAD ARLINGTON TN 38002
Andrew C. Morton officer: SVP, Chief Human Resources Ofr 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Lance A Berry officer: EVP, Chief Finan./Op. Officer 5677 AIRLINE ROAD, ARLINGTON TN 38002
Julie D. Dewey officer: SVP, Chief Comm. Officer 1023 CHERRY ROAD MEMPHIS TN 38117
Kevin D Cordell officer: EVP, Chief Global Comm Officer C/O WRIGHT MEDICAL GROUP, INC. 1023 CHERRY ROAD MEMPHIS TN 38117
Robert J Palmisano director, officer: President and Chief Executive 110 HARTWELL AVENUE, LEXINGTON MA 02173
Peter Cooke officer: Pres. Emerging Markets AUS/JAP 5677 AIRLINE ROAD ARLINGTON TN 38002

Wright Medical Group NV (Wright Medical Group NV) Headlines

From GuruFocus